Tenoxicam is a non-steroidal anti-inflammatory drug. It is manufactured by Roche under the tradename Mobiflex. It is available in the 
United Kingdom as a prescription-only drug. Tenoxicam belongs to the class of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs). It is used to relieve inflammation, swelling, stiffness, and pain associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis (a type of arthritis involving the spine), tendinitis (inflammation of a tendon), bursitis (inflammation of a bursa, a fluid-filled sac located around joints and near the bones), and periarthritis of the shoulders or hips (inflammation of tissues surrounding these joints).
The drug is contraindicated for patients who: are seniors who have been given anesthesia or surgery; are at risk of increased bleeding or kidney failure; have an active inflammatory disease involving the stomach or intestine (e.g., ulcerative colitis); have an active stomach or intestinal ulcer; have had an acute asthmatic attack, hives, rhinitis (inflammation of the inner lining of the nasal passage), or other allergic reactions caused by Aspirin or other nonsteroidal anti-inflammatory drugs (e.g. diclofenac, ibuprofen, indomethacin, naproxen).
United Kingdom as a prescription-only drug. Tenoxicam belongs to the class of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs). It is used to relieve inflammation, swelling, stiffness, and pain associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis (a type of arthritis involving the spine), tendinitis (inflammation of a tendon), bursitis (inflammation of a bursa, a fluid-filled sac located around joints and near the bones), and periarthritis of the shoulders or hips (inflammation of tissues surrounding these joints).
